Table 4.
| Outcomes | Total (N=313) | Survivors (n=212 [67.7%]) | Nonsurvivors (n=101 [32.3%]) | P valuec |
|---|---|---|---|---|
| Active patients | 14 (4.5) | NA | NA | NA |
| Discharge disposition | ||||
| Home or LTCF | 189 (60.4) | NA | NA | NA |
| Long-term acute care hospitals | 8 (2.6) | NA | NA | NA |
| Transferred for ECMO | 1 (0.3) | NA | NA | NA |
| Died | 88 (28.1) | NA | NA | NA |
| Hospice | 13 (4.2) | NA | NA | NA |
| Time from illness onset to admission (d) | 2 (1-7) | 3 (1-7) | 2 (1-5) | .04 |
| Time from illness onset to ICU admission (d) | 4 (1-8) | 5 (2-9.25) | 3 (1-7.75) | .09 |
| Hospital length of stay (d) | 7 (4-11) | 6 (4-10) | 7 (3-12) | .46 |
| Time from illness onset to outcome (d) | 10 (7-16) | 9 (7.0-16.75) | 10 (6.5-16.0) | .89 |
a
COVID-19 = coronavirus disease 2019; ECMO = extracorporeal membrane oxygenation = ICU, intensive care unit; LTCF = long-term care facility; NA = not applicable.
b
Categorical variables are presented as number (%). Continuous variables are presented as median (interquartile range).
c
P values indicate differences between survivors and nonsurvivors. P<.05 was considered statistically significant.